Lotus M Neidemire-Colley

PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease.

R. Garzon, G. Behbehani, R. Baiocchi, 2020, JCI insight.

CRISPR/CAS9 Gene Editing of MIR155HG in Primary Human T Cells to Prevent Acute Graft-Versus-Host Disease

R. Garzon, P. Malik, Yandi Gao, 2022, Blood.

Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-Versus-Host Disease

Ben J. Powell, G. Bollag, S. Devine, 2021, Frontiers in Oncology.

Role of endothelial cells in graft-versus-host disease

A. Dorrance, M. Guimond, Parvathi Ranganathan, 2022, Frontiers in Immunology.

CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model

M. Karunasiri, Olimjon Toirov, Parvathi Ranganathan, 2024, Blood advances.